姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
Cai,Yi-Ru | Chairman | 7.14% | |
Vacancy | Vice Chairman | ||
Zhu,Fu-Chun | Independent Director | 0.00% | |
Lin,Fu-Kun | Independent Director | 0.00% | |
Huang,Zhen-Wen | Independent Director | 0.00% | |
Liu,Yi-Shan | Independent Director | 0.00% | |
Ceng,Zhi-Hua | Independent Director | 0.00% | |
Wei,Zhi-Da | Director | 1.14% | |
Zhang,Li-Qiu | Director | 1.23% | |
Zhang,Wen-Zheng | Director | 1.03% |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Operating income | 612 | 728 | 2,697 |
Operating cost | 468 | 399 | 1,405 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
Operating gross profit (loss) | 144 | 329 | 1,292 |
Unrealized profit (loss) on sales of goods | - | - | - |
Realized profit (loss) on sales of goods | - | - | - |
Operating gross profit (loss), net | 144 | 329 | 1,292 |
Operating expenses | 76,621 | 60,235 | 44,663 |
Other gain (loss), net | - | - | - |
Operating profit (loss) | -76,477 | -59,906 | -43,371 |
Non-operating income and expenses | 1,960 | 3,115 | 3,564 |
Net profit (loss) before tax | -74,517 | -56,791 | -39,807 |
Income tax expense (benefits) | 0 | -5,009 | -8,070 |
Net profit (loss) of ongoing business for the current period | -74,517 | -51,782 | -31,737 |
Profit (loss) of closed units | - | - | - |
Profit (loss) of non-jointly controlled equity before merger | - | - | - |
Net profit (loss) for the current period | -74,517 | -51,782 | -31,737 |
Other comprehensive profit (loss), net | - | - | - |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
Total comprehensive profit and loss for the current period | -74,517 | -51,782 | -31,737 |
Net profit (loss) attributable to owners of parent company | - | - | - |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Net profit (loss) attributable to non-controlling interests | - | - | - |
Comprehensive profit (loss) attributable to owners of parent company | - | - | - |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
Basic earnings per share (yuan) | -2 | -2 | -1 |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Net cash inflow (outflow) from operating activities | - | - | - |
Net cash inflows (outflows) from investing activities | - | - | - |
Net cash inflow (outflow) from financing activities | - | - | - |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
Increase (decrease) in cash and cash equivalents in the current period | - | - | - |
Beginning balance of cash and cash equivalents | - | - | - |
Ending balance of cash and cash equivalents | - | - | - |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Current asset | 202,863 | 83,490 | 133,690 |
Non-current asset | 45,313 | 44,557 | 48,274 |
Total asset | 248,176 | 128,047 | 181,964 |
Current liability | 10,672 | 6,994 | 8,385 |
Non-current liability | 194 | 0 | 1,384 |
Total liability | 10,866 | 6,994 | 9,769 |
share capital | 323,448 | 250,000 | 250,000 |
Equity - secruity token | - | - | - |
capital reserve | 117,966 | 640 | - |
retained earning | -204,104 | -129,587 | -77,805 |
Other equity | - | - | - |
Treasury stock | - | - | - |
Total equity attributable to owners of parent company | - | - | - |
Equity attributable to former owner of business combination under common control | - | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - | - |
Non-controlling interests | - | - | - |
Total Equity | 237,310 | 121,053 | 172,195 |
Share capital awaiting retirement (unit: share) | - | - | - |
Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
Net asset value per share | 7 | 4 | 6 |